The invention relates to compounds that include peptide and peptidomimetics that inhibit estrogen receptor dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.

 
Web www.patentalert.com

< Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient

> Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment

> Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
~ 00548